The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study)Cihan Altın, Mehdi Zoghi, Mehmet Mustafa Yılmaz et al.|Unknown|2022Cited by 3